alcohol & drug experts inc.

1727 veterans memorial hwy
suite 206
islandia, new york 11749

NYS Entity Status
ACTIVE

NYS Filing Date
MARCH 27, 2014

NYS DOS ID#
4552139

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - ALCOHOL & DRUG EXPERTS INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Google Sets Limits on Addiction Treatment Ads, Citing Safety
    By MICHAEL CORKERY - Friday Sep 15, 2017

    The unusual restrictions will limit a popular marketing tool in the $35 billion business of treating opioid addicts, alcoholics and others.

    Source: NYT > Home Page
  • Ryder Trucks Launches Campaign With 'Inc.'
    Tuesday Sep 19, 2017

    "The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."

    Source: Media Post: Social Media & Marketing Daily
  • A Drug Maker Spends Big in Washington to Make Itself Heard
    By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017

    Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.

    Source: NYT > Home Page
  • Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers
    By KATIE THOMAS and CHARLES ORNSTEIN - Monday Sep 18, 2017

    Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too.

    Source: NYT > Home Page
  • Abbvie’s hep C drug pricing threatens Gilead’s dominance
    By Max Nisen - Tuesday Aug 8, 2017

    Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.

    Source: SFGATE.com: Business and Technology News
  • Insurers Battle Families Over Costly Drug for Fatal Disease
    By KATIE THOMAS - Thursday Jun 22, 2017

    The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

    Source: NYT > Home Page
alcohol amp drug experts inc islandia ny